The cell fragments play a role in the body’s first line of defense against bacterial infection, helping white blood cells grab blood-borne bacteria in the liver.
Advertisement
The Scientist
Most Recent
A panel of advisors says that the agency should loosen restrictions on the sale of a diabetes drug with a spotty clinical safety record.
A mass poisoning of 105 patients treated with an untested medication spurred Congress to empower the US Food and Drug Administration to monitor drug safety.
Malaria parasites transmitted via mosquitoes elicit a more effective immune response and cause less severe infection than those directly injected into red blood cells.
The activity of one type of immune cell helps regrow the limbs of amputated salamanders.
From now on, US physicians and researchers will have to get approval from the FDA before they can perform a stool transplant.
A new class of immune cell could protect against type 1 diabetes by suppressing other immune cells.
Research Associate, Perelman School of Medicine, University of Pennsylvania. Age: 27
After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.
Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
